Securities Class Action Deadlines Loom for Paysafe, Enphase, and Picard Medical

The legal landscape for several high-profile companies is tightening as Faruqi & Faruqi, LLP, a leading national securities law firm, intensifies its efforts to organize class action lawsuits. The firm has issued formal reminders to investors of Paysafe (PSFE), Picard Medical (PMI), and Enphase Energy (ENPH), setting a series of critical deadlines in April 2026 for shareholders to seek lead plaintiff status. These developments highlight a broader trend of increased litigation in sectors ranging from fintech and renewable energy to medical technology, often triggered by stock price volatility following earnings reports or regulatory disclosures.

Paysafe, a global payments platform, is facing a lead plaintiff deadline of April 7, 2026. This legal pressure comes on the heels of the company's mixed fourth-quarter 2025 financial results, which were released in early March. While the company introduced its fiscal year 2026 outlook, the subsequent legal notices suggest that investors may be questioning the transparency or accuracy of prior financial guidance. In the fintech sector, such lawsuits typically allege violations of the Securities Exchange Act of 1934, specifically focusing on whether the company made materially false or misleading statements regarding its growth trajectory or regulatory compliance.

“

The firm has issued formal reminders to investors of Paysafe (PSFE), Picard Medical (PMI), and Enphase Energy (ENPH), setting a series of critical deadlines in April 2026 for shareholders to seek lead plaintiff status.

Enphase Energy, a prominent player in the solar technology market, is under even broader legal scrutiny. With a deadline of April 20, 2026, Enphase is being targeted not only by Faruqi & Faruqi but also by other major firms like the Rosen Law Firm. The renewable energy sector has faced significant headwinds over the past year, including fluctuating demand in European markets and shifting interest rate environments that affect consumer financing for solar installations. The litigation against Enphase likely centers on how the company communicated these market shifts to its investors and whether it adequately disclosed inventory levels and revenue projections during periods of peak volatility.

Picard Medical, representing the healthcare and medical technology sector, faces an April 13, 2026, deadline. Litigation in this space often revolves around the progress of clinical trials, FDA approval timelines, or the commercial viability of new medical devices. For Picard Medical, the class action notice serves as a warning to the market that internal expectations may not have aligned with the public disclosures provided to shareholders, a common flashpoint for securities fraud allegations.